NeuroSense Therapeutics Ltd. Warrants (NRSNW) Live Share Price, Invest From India

NeuroSense Therapeutics Ltd. Warrants Stock Performance

as on July 2, 2026 at 2:16 pm IST

$0.07
Day's Price Range
$0.07
$0.07
52 Week's Low
52 Week's High
52-Week Price Range
$0.07
100.00%
Downside
-100.00%
Upside

NeuroSense Therapeutics Ltd. Warrants share price movements today

Previous Close: $0.06
Open: $0.07
Volume: 700.0
Day's Low - High: $0.07 - $0.07

NeuroSense Therapeutics Ltd. Warrants Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

NeuroSense Therapeutics Ltd. Warrants Stock Fundamentals & Key Indicators

Check NeuroSense Therapeutics Ltd. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-2174.98%

NeuroSense Therapeutics Ltd. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of NeuroSense Therapeutics Ltd. Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
NeuroSense Therapeutics Ltd. Warrants	NA	$-	NA	NA	0.00%	NA

NeuroSense Therapeutics Ltd. Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-
Operating Income	-2	-3	-2	-3	-2	-3	-2	-1
EBITDA	-2	-5	2	-	-2	0	-2	-
Interest Expense	0	0	0	2	2	2	0	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-2	-5	0	-2	-5	0	-2	-1
Income Tax Expense	0	-2	5	-	0	-	-	-
Net Income	-2	-5	0	-2	-5	0	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

NeuroSense Therapeutics Ltd. Warrants Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	-
Operating Income	-1	-2	-5	-13	-12	-9	-11
EBITDA	-1	-2	-2	-12	-9	-9	-11
Interest Expense	0	0	1	0	0	0	-
Depreciation	-	0	0	0	0	0	0
Income Before Tax	-1	-2	-4	-12	-10	-10	-11
Income Tax Expense	0	0	-1	-1	0	-	-
Net Income	-1	-2	-4	-12	-10	-10	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

NeuroSense Therapeutics Ltd. Warrants Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Income	0	0	-2	0	0	0	-1	0
Operating Cash Flow	0	-	-	-	-	-	-	0
Investing Cash Flow	-	-	-	-	-	-	-	0
Financing Cash Flow	-	-	-	-	-	-	-	0
Change in Cash	5	-2	-	-2	-	-	-	-

NeuroSense Therapeutics Ltd. Warrants Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-4	-12	-10	-10	-11
Operating Cash Flow	0	-1	-7	-8	-10	-7
Investing Cash Flow	0	0	-3	3	0	0
Financing Cash Flow	0	11	3	3	10	4
Change in Cash	0	10	-7	0	0	-3

About NeuroSense Therapeutics Ltd. Warrants

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Organisation	NeuroSense Therapeutics Ltd. Warrants
Headquarters	Building B, Herzliya, Israel, 4672562
Industry	Health Care
CEO	Mr. Alon Ben-Noon
E-voting on shares	Click here to vote

Key Management of NeuroSense Therapeutics Ltd. Warrants

Name	Title
Mr. Alon Ben-Noon	Co-Founder, CEO & Director
Mr. Or Eisenberg	Chief Financial Officer
Dr. Niva Russek-Blum Ph.D.	Chief Technology Officer
Ms. Yael Barak	VP of Quality & Compliance
Ms. Keren Pushett	Head of HR

FAQs

What is NeuroSense Therapeutics Ltd. Warrants share price today?

NeuroSense Therapeutics Ltd. Warrants share price today is $0.07 as on July 2, 2026 at 8:46 am IST at the close of the market. NeuroSense Therapeutics Ltd. Warrants share today touched a day high of $0.07 and a low of $0.07.

What is the 52 week high and 52 week low for NeuroSense Therapeutics Ltd. Warrants share?

NeuroSense Therapeutics Ltd. Warrants share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. NeuroSense Therapeutics Ltd. Warrants stock price today i.e. July 2, 2026 at 8:46 am IST is closed at $0.07,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in NeuroSense Therapeutics Ltd. Warrants Stock (NRSNW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for NeuroSense Therapeutics Ltd. Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NeuroSense Therapeutics Ltd. Warrants Shares that will get you 21.4286 shares as per NeuroSense Therapeutics Ltd. Warrants share price of $0.07 per share as on July 2, 2026 at 8:46 am IST.

What is the minimum amount required to buy NeuroSense Therapeutics Ltd. Warrants Stock (NRSNW) from India?

Indian investors can start investing in NeuroSense Therapeutics Ltd. Warrants (NRSNW) shares with as little as ₹95.2 or $1 (as of July 5, 2026 at 6:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in NeuroSense Therapeutics Ltd. Warrants stock (as per the Rupee-Dollar exchange rate as on July 5, 2026 at 6:39 am IST). Based on NeuroSense Therapeutics Ltd. Warrants share’s latest price of $0.07 as on July 2, 2026 at 8:46 am IST, you will get 142.8571 shares of NeuroSense Therapeutics Ltd. Warrants. Learn more about fractional shares .